Wu NW, Lyu XF, An ZM, Li SY. Adiposity in Chinese people with type 1 diabetes. World J Diabetes 2024; 15(7): 1404-1408 [PMID: 39099808 DOI: 10.4239/wjd.v15.i7.1404]
Corresponding Author of This Article
She-Yu Li, MD, Associate Professor, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, Sichuan Province, China. lisheyu@scu.edu.cn
Research Domain of This Article
Endocrinology & Metabolism
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Diabetes. Jul 15, 2024; 15(7): 1404-1408 Published online Jul 15, 2024. doi: 10.4239/wjd.v15.i7.1404
Adiposity in Chinese people with type 1 diabetes
Nian-Wei Wu, Xia-Fei Lyu, Zhen-Mei An, She-Yu Li
Nian-Wei Wu, Zhen-Mei An, She-Yu Li, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
Xia-Fei Lyu, Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
She-Yu Li, Department of Guideline and Rapid Recommendation, Chinese Evidence-based Medicine Center, Cochrane China Center and MAGIC China Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
Co-corresponding authors: Zhen-Mei An and She-Yu Li.
Author contributions: Wu NW prepared the first draft of the manuscript; Wu NW and Lyu XF were responsible for figure plotting, preparation and submission of the manuscript. Both Li SY and An ZM have played important and indispensable roles in the completion of the manuscript and thus qualified as the co-corresponding authors of this paper. Li SY and An ZM conceptualized and designed this editorial. Li SY contributed to the writing, and editing the manuscript, illustrations, and review of literature. An ZM supervised the whole process of this editorial. This collaboration between Li SY and An ZM is crucial for the publication of this manuscript.
Supported by1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University, No. ZYYC24001.
Conflict-of-interest statement: All the Authors have no conflict of interest related to the manuscript.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: She-Yu Li, MD, Associate Professor, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, Sichuan Province, China. lisheyu@scu.edu.cn
Received: February 28, 2024 Revised: April 30, 2024 Accepted: May 17, 2024 Published online: July 15, 2024 Processing time: 130 Days and 17.4 Hours
Abstract
Adiposity, synonymous with obesity, is prevalent among both children and adults with type 1 diabetes in China. Recent literature underscored the patho-physiological and socioeconomic factors associated with adiposity, and consistently highlighted its impact on cardiovascular, kidney, and metabolic diseases among Chinese individuals with type 1 diabetes. Addressing and managing adiposity in individuals with type 1 diabetes are complicated and entail comprehensive approaches including lifestyle modifications, cognitive-behavioral therapy, insulin dose titration, and other diabetes treatment medications. The condition calls for coordination among policymakers, researchers, clinicians, and patients.
Core Tip: Adiposity emerges as a significant health concern for individuals with type 1 diabetes in China as well as globally. Adiposity is associated with adverse health outcomes, including cardiovascular and kidney complications in people with type 1 diabetes. This article highlighted the approaches in addressing and managing adiposity in individuals with type 1 diabetes. The condition calls for coordination among policymakers, researchers, clinicians, and patients.
